Letter to the Editor: Antidepressant and Antisuicidal Effects of Esketamine in Adolescents with Major Depressive Disorder and Suicidal Ideation: A Case Series

J Child Adolesc Psychopharmacol. 2022 Aug;32(6):366-367. doi: 10.1089/cap.2022.0013. Epub 2022 Jun 16.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Antidepressive Agents / pharmacology
  • Antidepressive Agents / therapeutic use
  • Depressive Disorder, Major* / drug therapy
  • Humans
  • Ketamine* / therapeutic use
  • Suicidal Ideation

Substances

  • Antidepressive Agents
  • Esketamine
  • Ketamine